Takeda Wins Battle for Shire With $62 Billion Deal
Takeda Pharmaceutical Co. reached an agreement to buy Shire PLC. This ends a long battle for control of the European drugmaker and marks the biggest-ever overseas acquisition by a Japanese company.
Shire’s board agreed Takeda could buy it at $66.21 a share in a deal that valued the target at $62B. Both companies still need shareholders to sign off.
